Led by former Publix and Albertsons executive Dain Rusk, Fillex provides an open-access, automated infrastructure layer to help retail pharmacies, grocery chains, and health systems scale efficiently
Leverages Morrison’s track record of successfully launching and scaling platform businesses globally and accelerating network expansion, facilities development, and automation
Fillex, a national pharmacy logistics platform, today announced the launch of its business with an initial investment from Morrison, a leading global infrastructure investment firm managing more than US$30 billion in assets. Fillex will provide centralized, automated pharmacy fulfillment services to retail pharmacies, grocery chains, e-commerce providers, and health systems.
Fillex will be led by Chief Executive Officer Dain Rusk. Mr. Rusk most recently served as Vice President of Pharmacy for Publix Super Market, where he led the company’s pharmacy retail business unit, including pharmacy operations, central fill pharmacies, pharmacy administration, and specialty pharmacy. Prior to joining Publix Super Market, Mr. Rusk served as the Group Vice President of Pharmacy Operations at the Albertsons Companies, where he was responsible for all pharmacy operations.
Morrison Operating Partner Marvin Richardson, a highly experienced operator who brings over 40 years of healthcare and logistics industry experience across strategy and business development, will be joining Fillex’s board of directors as Chair.
“Our mission at Fillex is to transform prescription fulfillment to ensure essential community care is available on every corner by reducing the operational and capital burden on pharmacy providers,” said Mr. Rusk. “This enables them to run more efficiently while reclaiming essential time for patient care and improving clinical outcomes.”
“Fillex provides the missing infrastructure layer for modern pharmacy — an open-access platform that allows operators to scale, protect margins, and remain focused on patient care,” Mr. Richardson added.
The pharmacy industry currently faces a ‘triple threat’ of rising operational costs, shrinking reimbursement margins, and acute labor shortages. By outsourcing the capital-intensive fulfillment process to Fillex, providers can redirect their staff toward high-value clinical services and patient consultation. Backed by Morrison’s significant operational resources and strong track record of scaling platform investments, Fillex is uniquely positioned to meet the industry demand for centralized pharmacy fulfillment.
“Since 1988, Morrison has been building infrastructure businesses that meet evolving societal needs both in the U.S. and globally. While AI-powered automation has the potential to revolutionize pharmacy fulfillment, these next-generation capabilities have remained out of reach for most because they lack the capital, operating scale, and technical capability required to build and manage such complex infrastructure,” said William Smales, Chief Investment Officer at Morrison.
“The launch of Fillex bridges this critical gap by leveraging Morrison’s deep in-house expertise and our long-standing track record of investing in essential infrastructure. We are excited by the business’s strong fundamentals and, under Dain’s vision and leadership, we look forward to building Fillex into a platform that enables better, more accessible care for society.”
Perry Offutt, Morrison’s New York-based Partner, added, “We are very excited to bring this powerful ‘idea that matters’ to market for the benefit of pharmacies, customers, and our investors. This investment underscores the need for infrastructure capital to provide high-quality logistics and fulfillment facilities, drive new efficiency gains, and expand the capacity and resiliency of the entire healthcare system.”
For more information, visit: www.fillexrx.com
